{"id":"pra","safety":{"commonSideEffects":[{"rate":null,"effect":"Elevated liver enzymes"},{"rate":null,"effect":"Infusion-related reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL3545239","moleculeType":"Unknown"},"_dailymed":{"setId":"3e5c6728-ece3-40f7-9e36-cff71f168cd8","title":"ANALPRAM HC (HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE) CREAM [LEGACY PHARMA USA INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Prasifungin is an echinocandin-class antifungal that works by inhibiting β-1,3-glucan synthase, a key enzyme in fungal cell wall biosynthesis. This leads to disruption of the fungal cell wall integrity and fungal cell death. It has broad-spectrum activity against Candida, Aspergillus, and other clinically important fungi.","oneSentence":"PRA (prasifungin) is an antifungal agent that inhibits fungal cell wall synthesis by targeting glucan synthase.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T06:22:24.033Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Invasive candidiasis"},{"name":"Invasive aspergillosis"}]},"trialDetails":[{"nctId":"NCT05320822","phase":"NA","title":"A Pragmatic Rehabilitation Intervention: The Active Rehab Study","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-06-04","conditions":"Concussion, Brain","enrollment":130},{"nctId":"NCT07379957","phase":"","title":"Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2026-01","conditions":"Kidney Transplantation","enrollment":450},{"nctId":"NCT05498038","phase":"NA","title":"Exercise Reset for Concussion in a Military Environment","status":"RECRUITING","sponsor":"State University of New York at Buffalo","startDate":"2024-08-07","conditions":"Brain Concussion","enrollment":168},{"nctId":"NCT07323459","phase":"NA","title":"A Midwife-Led Psychoeducational Intervention to Reduce Pregnancy-Related Anxiety in Low-Risk Pregnant Women","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2026-01-01","conditions":"Pregnancy-Related Anxiety (PrA), Fear of Childbirth","enrollment":80},{"nctId":"NCT05345717","phase":"PHASE1, PHASE2","title":"Novel Desensitization Kidney Transplantation","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2022-05-01","conditions":"Kidney Transplantation, End Stage Kidney Disease (ESRD)","enrollment":5},{"nctId":"NCT05714514","phase":"","title":"Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hansa Biopharma AB","startDate":"2023-04-21","conditions":"Kidney Transplantation in Highly Sensitized Patients","enrollment":64},{"nctId":"NCT05049850","phase":"PHASE2","title":"A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation","status":"TERMINATED","sponsor":"Hansa Biopharma AB","startDate":"2022-12-16","conditions":"Kidney Transplantation in Highly Sensitized Patients","enrollment":3},{"nctId":"NCT05835882","phase":"NA","title":"Blood Salvage From Liver Donors: a Feasibility Pilot Study","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-06-01","conditions":"Liver Transplantation, Erythrocyte Transfusion","enrollment":10},{"nctId":"NCT04935177","phase":"PHASE3","title":"Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx","status":"COMPLETED","sponsor":"Hansa Biopharma AB","startDate":"2021-10-14","conditions":"Kidney Transplantation in Highly Sensitized Patients","enrollment":64},{"nctId":"NCT06963138","phase":"NA","title":"Comparative Study and Validation of New Methodologies for Measuring Addition","status":"COMPLETED","sponsor":"Essilor International","startDate":"2025-03-31","conditions":"Presbyopia, Near Vision, Refraction Error","enrollment":54},{"nctId":"NCT05862766","phase":"EARLY_PHASE1","title":"Isatuximab in Lung Transplant Recipients","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2024-12-01","conditions":"Antibody-mediated Rejection, Allosensitization","enrollment":""},{"nctId":"NCT05369975","phase":"PHASE3","title":"Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hansa Biopharma AB","startDate":"2022-04-19","conditions":"Kidney Transplantation in Highly Sensitized Patients","enrollment":225},{"nctId":"NCT05753930","phase":"PHASE2","title":"Imlifidase Prior to Kidney Transplant in Highly Sensitised Children","status":"RECRUITING","sponsor":"Hansa Biopharma AB","startDate":"2023-06-02","conditions":"Kidney Transplantation in Highly Sensitized Patients","enrollment":10},{"nctId":"NCT06407999","phase":"NA","title":"Pressure Relief Algorithm Eval","status":"WITHDRAWN","sponsor":"SleepRes Inc.","startDate":"2025-01-01","conditions":"Obstructive Sleep Apnea","enrollment":""},{"nctId":"NCT04057742","phase":"","title":"AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2019-10-07","conditions":"Kidney Transplant Failure and Rejection","enrollment":52},{"nctId":"NCT03728088","phase":"","title":"Cross-sectional Analysis of Non-technical Attributes and Surgical Experience in Surgical Staff, Trainees and Applicants.","status":"ENROLLING_BY_INVITATION","sponsor":"University Ghent","startDate":"2016-09-01","conditions":"Healthy Volunteers","enrollment":120},{"nctId":"NCT05431712","phase":"","title":"Impact of Donor-Specific Antibodies in (Highly-) Immunized Living Donor Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2010-01-01","conditions":"Renal Failure","enrollment":252},{"nctId":"NCT04827186","phase":"NA","title":"Spleen Transplant in Solid Organ Transplantation","status":"WITHDRAWN","sponsor":"University of Illinois at Chicago","startDate":"2021-03-26","conditions":"Kidney Transplant Rejection, Positive FCXM (T or B Cell Positive), Positive CDC Cross-Match (B Cell Positive)","enrollment":""},{"nctId":"NCT06115577","phase":"","title":"Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes","status":"COMPLETED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2012-10-01","conditions":"Endometrial Hyperplasia Without Atypia, Endometrial Hyperplasia With Atypia, Endometrial Cancer","enrollment":92},{"nctId":"NCT00476515","phase":"PHASE1","title":"Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2007-03","conditions":"Kidney Insufficiency","enrollment":""},{"nctId":"NCT04878887","phase":"NA","title":"DRA vs PRA for US-guided Radial Artery Catheterization in ICU","status":"COMPLETED","sponsor":"University Tunis El Manar","startDate":"2021-03-26","conditions":"Ultrasonography","enrollment":94},{"nctId":"NCT05064046","phase":"NA","title":"Educating Providers About Lung Screening","status":"COMPLETED","sponsor":"Georgetown University","startDate":"2021-10-27","conditions":"Lung Cancer","enrollment":77},{"nctId":"NCT03803150","phase":"NA","title":"Evaluation of Preauricular Retromandibular Anteroparotid Versus Retromandibular Through Parotid Approach","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-02-01","conditions":"Subcondylar Process of Mandible Open Fracture, Facial Nerve Injuries","enrollment":20},{"nctId":"NCT04066218","phase":"","title":"Sexual Function Screening in Childhood Cancer Survivors","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2019-09-16","conditions":"Childhood Cancer, Survivorship, Sexual Dysfunction","enrollment":24},{"nctId":"NCT04608344","phase":"PHASE1","title":"Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2020-11-04","conditions":"Rheumatoid Arthritis","enrollment":27},{"nctId":"NCT02651844","phase":"NA","title":"Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B.","status":"COMPLETED","sponsor":"Hospital Provincial Magdalena V. de Martínez","startDate":"2016-04","conditions":"Breast Cancer","enrollment":20},{"nctId":"NCT03048045","phase":"","title":"Long-term Results After Systematic Periodontal Therapy","status":"UNKNOWN","sponsor":"Goethe University","startDate":"2015-06","conditions":"Tooth Loss","enrollment":100},{"nctId":"NCT02625090","phase":"PHASE2","title":"An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy","status":"TERMINATED","sponsor":"UCB Biopharma SRL","startDate":"2015-12-03","conditions":"Highly Drug-resistant Focal Epilepsy","enrollment":42},{"nctId":"NCT04429464","phase":"NA","title":"AcQBlate Force Confirmatory Study for Atrial Arrhythmias","status":"WITHDRAWN","sponsor":"Acutus Medical","startDate":"2020-10-01","conditions":"Atrial Arrhythmias","enrollment":""},{"nctId":"NCT02790437","phase":"PHASE2","title":"A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test","status":"COMPLETED","sponsor":"Hansa Biopharma AB","startDate":"2016-06","conditions":"Kidney Failure, Chronic","enrollment":19},{"nctId":"NCT02013037","phase":"PHASE3","title":"The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2012-11","conditions":"Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant, Left Ventricular Dysfunction","enrollment":36},{"nctId":"NCT04114188","phase":"PHASE2","title":"Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)","status":"COMPLETED","sponsor":"Prof. Dr. Petra Reinke","startDate":"2016-12-15","conditions":"Renal Transplant Rejection","enrollment":68},{"nctId":"NCT04092751","phase":"PHASE1","title":"Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects","status":"COMPLETED","sponsor":"Scynexis, Inc.","startDate":"2019-11-22","conditions":"Pharmacokinetics","enrollment":28},{"nctId":"NCT04071561","phase":"","title":"Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions","status":"COMPLETED","sponsor":"University of Basel","startDate":"2018-11-19","conditions":"Adrenal Tumor, Adrenal Mass, Pheochromocytoma","enrollment":14},{"nctId":"NCT02814851","phase":"NA","title":"Evaluation of Cardiac Hemodynamic Modifications During Temporary Left Atrial Appendage Occlusion","status":"COMPLETED","sponsor":"Brugmann University Hospital","startDate":"2016-08-01","conditions":"Cardiac Surgery","enrollment":20},{"nctId":"NCT00407160","phase":"","title":"A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2004-08","conditions":"Kidney Diseases","enrollment":21},{"nctId":"NCT02814552","phase":"NA","title":"OPTImizing Precision of Hypertension Care to Maximize Blood Pressure Control Pilot (OPTI-BP Pilot)","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-06-18","conditions":"High Blood Pressure","enrollment":47},{"nctId":"NCT03193073","phase":"NA","title":"Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient","status":"SUSPENDED","sponsor":"Omnia Mohammed Hashem","startDate":"2018-09-01","conditions":"Anemia of Chronic Kidney Disease, Endothelial Dysfunction, Left Ventricular Hypertrophy","enrollment":80},{"nctId":"NCT00670774","phase":"PHASE1, PHASE2","title":"Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant","status":"COMPLETED","sponsor":"Mark Stegall","startDate":"2008-03","conditions":"Kidney Transplant","enrollment":31},{"nctId":"NCT01106027","phase":"PHASE1, PHASE2","title":"Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2010-03","conditions":"Kidney Transplant","enrollment":2},{"nctId":"NCT00275509","phase":"PHASE3","title":"Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2007-01","conditions":"Kidney Failure, Chronic","enrollment":56},{"nctId":"NCT01676025","phase":"NA","title":"Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2012-09","conditions":"Adrenal Disease","enrollment":83},{"nctId":"NCT01135485","phase":"","title":"Evaluation of Panel Reactive Antibody in Children Following Stage I Palliation for Hypoplastic Left Heart Syndrome","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-03","conditions":"Congenital Heart Disease","enrollment":33},{"nctId":"NCT03094728","phase":"","title":"Role of Human Leukocyte Antigen Matching in Liver Transplantation and Its Relation to Outcomes","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2015-01-01","conditions":"Liver Transplantation","enrollment":24},{"nctId":"NCT03073421","phase":"NA","title":"Positive Pregnancy Program","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2012-06-29","conditions":"HIV Positive Pregnant Women","enrollment":25},{"nctId":"NCT00586716","phase":"NA","title":"Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients","status":"TERMINATED","sponsor":"Loma Linda University","startDate":"2004-11","conditions":"End Stage Renal Disease","enrollment":22},{"nctId":"NCT02843295","phase":"NA","title":"Catalytic Antibodies to Predict Uninvasively Late Transplant Failure","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2010-09","conditions":"Renal Transplantation","enrollment":100},{"nctId":"NCT02755909","phase":"NA","title":"The Effect of Pre-anesthetic Education on Cardiac Surgery Patients' Anxiety Level","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2015-12","conditions":"Cardiac Surgery Patients","enrollment":36},{"nctId":"NCT02616458","phase":"NA","title":"The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2010-11","conditions":"Otitis Media","enrollment":310},{"nctId":"NCT00167791","phase":"NA","title":"Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant","status":"WITHDRAWN","sponsor":"University of Wisconsin, Madison","startDate":"2005-07","conditions":"End Stage Renal Disease","enrollment":""},{"nctId":"NCT01658657","phase":"NA","title":"A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2012-10","conditions":"Hypertension, Plasma Renin Activity","enrollment":17},{"nctId":"NCT00784979","phase":"PHASE4","title":"Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation","status":"COMPLETED","sponsor":"Tampa General Hospital","startDate":"2002-01","conditions":"End Stage Renal Disease","enrollment":26},{"nctId":"NCT00460824","phase":"","title":"A Retrospective Review - Anti-HLA Antibodies","status":"WITHDRAWN","sponsor":"Emory University","startDate":"1988-07","conditions":"Congenital Disorders","enrollment":""},{"nctId":"NCT01334281","phase":"","title":"An In-vitro Standardization of B Cell Elispot Assays","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2008-02","conditions":"Transplant Sensitization, Panel Reactive Antibody, Sensitization to HLA Antigens","enrollment":19},{"nctId":"NCT00143741","phase":"PHASE1","title":"Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2005-05","conditions":"End-Stage Kidney Disease","enrollment":20},{"nctId":"NCT00923156","phase":"PHASE2","title":"Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-05","conditions":"Heart Failure","enrollment":123},{"nctId":"NCT00298883","phase":"PHASE1","title":"Desensitization of Renal Transplant Candidates","status":"COMPLETED","sponsor":"University of Florida","startDate":"2006-02","conditions":"End Stage Renal Disease, Kidney Transplantation","enrollment":9},{"nctId":"NCT00834600","phase":"NA","title":"Renin Profiling in Selection of Initial Antihypertensive Drug","status":"COMPLETED","sponsor":"The Louis & Rachel Rudin Foundation","startDate":"2005-12","conditions":"Hypertension","enrollment":185},{"nctId":"NCT00113269","phase":"PHASE4","title":"Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2005-05","conditions":"Kidney Transplantation","enrollment":501},{"nctId":"NCT01239927","phase":"PHASE2, PHASE3","title":"Hartmann vs R/A in Peritonitis by Perforated Diverticulitis","status":"COMPLETED","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"2000-01","conditions":"Peritonitis Caused by Perforated Left-sided Colon Diverticulitis","enrollment":100},{"nctId":"NCT00423254","phase":"PHASE1","title":"Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2007-02","conditions":"Ovarian, Melanoma, Renal","enrollment":12},{"nctId":"NCT00446459","phase":"PHASE2","title":"Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.","status":"COMPLETED","sponsor":"University of Washington","startDate":"2006-04","conditions":"Kidney Failure, Chronic, Diabetic Nephropathies, Glomerulonephritis, IGA","enrollment":45},{"nctId":"NCT00917345","phase":"","title":"Diagnosis of Primary Aldosteronism: Comparison of Post Captopril Active Renin Concentration and Plasma Renin Activity","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2008-01","conditions":"Primary Aldosteronism","enrollment":150},{"nctId":"NCT00693576","phase":"PHASE2, PHASE3","title":"The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2007-04","conditions":"Renal Transplantation","enrollment":82}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9203,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"PRA","genericName":"PRA","companyName":"Scynexis, Inc.","companyId":"scynexis-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PRA (prasifungin) is an antifungal agent that inhibits fungal cell wall synthesis by targeting glucan synthase. Used for Invasive candidiasis, Invasive aspergillosis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}